+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

Pharmaceutical Market in Denmark 2025-2029 - Product Thumbnail Image

Pharmaceutical Market in Denmark 2025-2029

  • Report
  • March 2025
  • 186 Pages
  • Denmark
From
Antibody Production Market - Global Forecast 2025-2032 - Product Thumbnail Image

Antibody Production Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
From
Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
From
From
From
Computer-Aided Drug Discovery Services Market, 2018-2030 - Product Thumbnail Image

Computer-Aided Drug Discovery Services Market, 2018-2030

  • Report
  • June 2018
  • 315 Pages
  • Global
From
From
From
From
From
Loading Indicator